Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

Autoreactive Germinal Centers: A Single Autoreactive B Cell Clone Can Drive Autoimmunity

Lara C. Pullen, PhD  |  October 16, 2017

A study in mice provides insight into the maturation of the self-reactive B cell response, contextualizing the epitope spreading observed in autoimmune disease. Researchers found that clonal expansion of wild type B cells in autoreactive germinal centers appeared to be at the heart of epitope spreading and the consequent autoimmune response…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Autoimmune diseaseautoreactive germinal centersB cells

Adalimumab + Methotrexate Effective for Uveitis in JIA

Lara C. Pullen, PhD  |  October 2, 2017

Research has found that taking adalimumab plus methotrexate is effective for patients with juvenile idiopathic arthritis-associated uveitis. However, these patients may also experience an increased incidence of adverse and serious adverse events compared with those taking only methotrexate…

Filed under:ConditionsOther Rheumatic ConditionsPediatric Conditions Tagged with:adalimumabJIAJuvenile Arthritis (JIA)MethotrexatePediatricPediatric RheumatologyUveitis

Insights into Precision Immunology for Research, RA & Infection

Lara C. Pullen, PhD  |  September 26, 2017

Research in precision immunology is in its early stages. But new insights into cohorts, RA gene expression and infection presented at FOCUS 2017 may benefit future research and patient care…

Filed under:ConditionsRheumatoid Arthritis Tagged with:FOCISImmunologyInfectionPrecision MedicineRheumatoid Arthritis (RA)

Many Drug Companies Fail to Conduct Timely Safety Checks on Medicines after FDA Approval

Gene Emery  |  September 22, 2017

(Reuters Health)—In the rush to approve new medicines, the U.S. Food and Drug Administration often requires drug companies to study possible side effects and alternative doses for medicines once they hit the broader market. A September 20 online analysis in the New England Journal of Medicine concludes that, in many cases, that’s not being done….

Filed under:Drug UpdatesEthics Tagged with:Dartmouth Institute for Health Policy and Clinical PracticeFDA approvalGilenya (fingolimod)Indivior's SuboxoneU.S. Food and Drug Administration

Treat-to-Target Strategy Evaluated for Fibromyalgia Care

Susan Bernstein  |  September 19, 2017

Treat-to-target is a widely used approach for rheumatoid arthritis, in which rheumatologists prescribe treatments to reach established benchmarks of disease activity.1 Is it time for a similar approach for fibro­myalgia treatment, even though its pathogenesis, disease-activity measures and treatment algorithms are less well understood? Three fibromyalgia researchers present their case in a new paper, “Treat-to-Target…

Filed under:ConditionsPain SyndromesResearch RheumSoft Tissue Pain Tagged with:ACR Journal ReviewAmerican College of Rheumatology (ACR)criteriaFibromyalgiaPainResearchrheumatologyStrategyTreatment

ARHP Stands Up for Members and Patients

Jan Stevens, BA, & Afton L. Hassett, PsyD  |  September 17, 2017

Editor’s note: The new Pillar Talk column is developed by the ARHP Executive Committee in an effort to share information about ongoing activities related to our four pillars: Education, Practice, Research and Advocacy. ARHP volunteers are actively involved in the ACR’s efforts to advocate for the care of our patients and the rheumatology professionals who…

Filed under:Interprofessional PerspectiveLegislation & Advocacy Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)health professionalsLegislationmemberspatient carerheumatologyRheumPAC

Rheumatology & The Gender Pay Gap

Richard Quinn  |  September 8, 2017

On average, male rheumatologists earn 16.2%—or $38,493—more than female rheumatologists. Although the data seem jarring, a closer look at it is needed to truly understand the pay gap…

Filed under:Career DevelopmentProfessional Topics Tagged with:GenderrheumatologistSalaryWomen

ACR Seeks Legislation to Help Ease Workforce Shortage

Thomas R. Collins  |  August 16, 2017

With a shortage of rheumatologists in the U.S. already a problem and projected to get far worse, the ACR is advocating the passage of a variety of laws that would help narrow the gap. Legislation being fought for by ACR advocacy leaders involves streamlining visa processing for foreign physicians and promoting incentives for physicians to…

Filed under:Legislation & AdvocacyProfessional TopicsWorkforce Tagged with:H-1B visa programH.R. 2141/S. 898H.R. 2267S. 989workforce shortage

What Do Diabetes, Islet Cells & Autoimmunity Have in Common?

Simon M. Helfgott, MD  |  August 15, 2017

“Man may be the captain of his fate, but he is also the victim of his blood sugar.” —Wilfrid Oakley, MB BChir, an early pioneer in diabetes care Perusing the list of the most notable medical achievements in the 20th century, a reader may conclude that the discovery of insulin should rank in a category…

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:AutoimmuneCharles BestdiabetesdiscoveryDr. Frederick Bantingglucoseinsulinislet cellsPathogenesispatient careTreatment

Fellows' Forum Case Report: Hemophagocytic Lymphohistiocytosis

Fellows’ Forum Case Report: Hemophagocytic Lymphohistiocytosis

Anita Laloo, MB, BS, MPH, German Pihan, MD, & Robert H. Shmerling, MD  |  August 13, 2017

The patient was a 48-year-old woman who saw her primary care physician for a flu-like illness three months prior to admission. Her symptoms initially improved, but recurred one month later; she was treated symptomatically, and again symptoms resolved. Two months later, she presented to an outside facility’s emergency department with fever to 103ºF, with associated…

Filed under:ConditionsResearch Rheum Tagged with:case reportClinicalDiagnosisFellowsFellows Forumfeverhemophagocytic lymphohistiocytosisimmunodeficiencylymphomamalignancyoutcomepatient careResearchrheumatologysymptoms

  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 109
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences